Overview:
Fluocinonide topical is a medication that is used to treat a number of skin issues such as itching, redness, dryness, crusting, scaling, inflammation, and discomfort associated with conditions like eczema (a skin disorder leading to dryness, itchiness, and the development of red, scaly rashes) and psoriasis (a skin condition with red, scaly patches on certain body areas). Fluocinonide is a corticosteroid that reduces swelling, redness, and itching by activating natural chemicals in the skin. Fluocinonide helps manage and relieve symptoms of various skin disorders by regulating the body’s inflammatory response. The drug was approved by the United States Food and Drug Administration in 1971.
Drug Group:
Fluocinonide belongs to the corticosteroid drug class.
Available Doses and Dosage Forms:
Administer a thin coating to the afflicted area 2 to 4 times daily with 0.05 percent cream, gel, or ointment formulations.
Use a thin layer on the afflicted area once or twice daily for the 0.1 percent cream formula.
Although occlusive dressings are acceptable, they should be discontinued, and appropriate antimicrobial therapy should be initiated as soon as an infection appears.
Treatment should be limited to two weeks and not exceed 60 grams (g) each week.
For Patients:
How Does Fluocinonide Work for Eczema?
Eczema can present in 7 forms, 2 of which are contact dermatitis and atopic dermatitis. Depending on the skin tone, symptoms can appear differently. Treatment options include topical lotions, moisturizers, and antihistamines. Hospitalization may be necessary in extreme cases. It is crucial to obtain an accurate diagnosis because eczema can be mistaken for other conditions, such as psoriasis.
Fluocinolone is a synthetic corticosteroid used to treat several kinds of skin diseases. It works by inhibiting membrane permeability, modulating the immune system, and constricting blood vessels, thus reducing inflammation, swelling, redness, and itching.
What Are the Things to Inform the Doctor Before Taking Fluocinonide?
Before applying a topical Fluocinonide medication, people should provide the following details to the doctor:
If they are planning for surgery, including a dental operation.
In case of any allergies to Fluocinonide, other medications, or any chemicals in topical Fluocinonide products.
Mention all vitamins, nutritional supplements, prescription medications, and over-the-counter medications they intend to take. Make specific references for further topical and corticosteroid medicines.
Any current infections, other skin conditions, or a history of diabetes, liver illness, or Cushing's syndrome (a disorder brought on by high corticosteroid hormone levels).
If they intend to get pregnant, are nursing a baby, or are already pregnant. Those who become pregnant while taking Fluocinonide should get in touch with their doctor immediately.
How Is Fluocinonide Administered?
Topical Fluocinonide is available as a cream, gel, ointment, and solution, each with a different potency for topical application. It is usually used one to four times each day. Patients should carefully read the directions on prescription labels and, if necessary, ask their doctor or pharmacist for clarification. Fluocinonide must be taken exactly as prescribed, more or less frequently than that.
The first two weeks of treatment should improve the patient's skin condition. Patients should contact their doctor if their symptoms do not improve throughout this time.
Patients should use a tiny amount of Fluocinonide topical to cover the affected area with a thin film, then rub it gently. Hands should be washed immediately after application.
Patients should carefully read the directions before using it for the first time, and if necessary, ask their doctor or pharmacist for clarification.
Topical Fluocinonide should only be used topically (on the skin). It should not be eaten or come into contact with the mouth or eyes. Unless advised by the physician, avoid using this product on the face, genital and pubic areas, armpits, or wrinkles.
Unless the doctor instructs, avoid bandaging or wrapping the treated area. Such use could worsen side effects.
Using plastic pants or tight-fitting diapers is not advised when applying Fluocinonide to a child's diaper area. Side effects could worsen with such use.
Consult the doctor before using additional skin care products or preparations on the treated area.
If the treated region worsens or if pus, swelling, or burning occurs, contact the doctor.
Avoid stopping the medication suddenly without first consulting the doctor.
What Are the Side Effects?
Side effects from Fluocinonide are possible. If any of the below-mentioned symptoms are severe or persistent, let the doctor know:
Itching.
Irritation.
Dryness, redness, or cracking of the skin.
Burning sensation.
Any change in the skin color (hyperpigmentation or hypopigmentation).
Bruising of the skin.
Shiny appearance of the skin.
Red rash or bumps around the mouth (perioral dermatitis).
Small red or white bumps on the skin (folliculitis or steroid acne).
Contact the doctor immediately if any of the following symptoms appear:
Changes in the distribution of fat throughout the body.
Abrupt weight gain.
Redness, swelling, pus, or other skin infection symptoms where Fluocinonide was administered.
Severe skin rashes.
Fatigue (feeling of extreme tiredness).
Wasting of muscles.
Missed Dose:
If a dose is missed, apply the Fluocinonide topical as soon as possible upon recall. Otherwise, the missed dose should be skipped, and the regular dosing schedule should be continued if the next scheduled dose is approaching. Avoid applying two doses to make up for a missed dose.
Overdose:
If there is overdosage is suspected at any time, you must rush to the emergency department immediately.
Storage:
After use, immediately store the medicine securely in its original packaging away from moisture and heat. It is to be kept at room temperature. It is advised not to freeze or store it in the bathroom. Care must be taken to store all medications out of reach of children. All unnecessary medicines should be disposed of properly by participating in medicine take-back programs. It is strictly advised not to flush these medications down the toilet.
For Doctors:
Indication: Fluocinonide is a corticosteroid ointment intended to help people 12 years of age and older with itchy, inflammatory symptoms associated with corticosteroid-responsive dermatoses. It is recommended that the duration of Fluocinonide cream therapy not exceed two weeks in a row. The weekly cumulative dosage should also be no more than 60 grams. Due to the lack of documented safety data and the potential for the medicine to suppress the hypothalamic-pituitary-adrenal (HPA) axis, Fluocinonide cream cannot be used for more than 2 weeks. When the illness is under control, therapy should be stopped. The diagnosis may be reevaluated to ensure adequate management if no improvement is observed within the first 2 weeks of treatment.
Contraindication: Anyone with a history of known hypersensitivity to its ingredients should not use Fluocinonide cream.
What Is the Dosage?
For formulations containing 0.05 percent cream, gel, or ointment, apply a thin layer to the affected area 2 or 4 times daily.
Apply a thin layer of the 0.1 percent cream formula once or twice daily to the affected area.
While occlusive dressings are permissible, an infection should be stopped as soon as it manifests and the proper antimicrobial medication initiated.
The course of treatment should last no longer than two weeks and include no more than 60 grams (gms) every week.
What Are the Pharmacological Aspects of Fluocinonide?
Description
Molecular Formula - C26H32F2O7.
Molecular Weight - 494.58.
Fluocinonide is a white to off-white crystalline powder. It has almost no smell. It does not dissolve well in water and dissolves only slightly in alcohol.
The ointment contains 0.5 mg of Fluocinonide in each gram. The ointment base includes propylene glycol, glyceryl monostearate, white wax, propylene carbonate, and white petrolatum. These ingredients help keep the skin moist and create a protective layer. The active drug, Fluocinonide, is fully mixed and dissolved in this base.
Mechanism of Action: Fluocinonide is a topical corticosteroid. It reduces inflammation, itching, and redness, and it also narrows small blood vessels in the skin. The exact way it works is not fully understood. It is believed to increase the levels of certain proteins (lipocortins) that block phospholipase A2. This reduces the release of arachidonic acid, which is needed to produce inflammatory substances such as prostaglandins and leukotrienes.
Pharmacokinetics: The amount of drug absorbed through the skin depends on factors such as the formulation and the condition of the skin. Healthy skin absorbs less drug, while damaged or inflamed skin absorbs more. After it passes through the skin and enters the bloodstream, it behaves like other corticosteroids taken by other routes. It binds to plasma proteins, is mainly metabolized in the liver, and is excreted by the kidneys. Some metabolites may also be excreted in bile.
Toxicity (Cancer Risk, Genetic Effects, and Fertility):
Long-term animal studies have not been done to check whether Fluocinonide can cause cancer or affect fertility.
Laboratory tests and in vitro tests using human lymphocytes show that this medication does not cause mutations or chrooseme damages. However, one mouse micronucleus test showed a clastogenic effect and chromosome damage.
Warnings and Precautions:
Suppression of HPA Axis:
Some people develop symptoms like glucosuria, hyperglycemia, Cushing’s syndrome, and suppression of the hypothalamic-pituitary-adrenal (HPA) axis (reversible) with topical corticosteroids when they are absorbed systemically. Using stronger steroids, prolonged use, and occlusive dressings significantly increase the systemic absorption.
Individuals with an occlusive dressing or receiving a high dose of a strong topical steroid should have their HPA axis suppression checked regularly. Tests such as urinary free cortisol and ACTH (adrenocorticotropic hormone) stimulation can be used to obtain this information. If HPA axis suppression is found, stopping the medication, reducing the frequency of use, or switching to a less potent corticosteroid might be necessary.
When the drug is stopped, most patients quickly and fully regain normal HPA axis function. Rarely, withdrawal symptoms could appear, requiring systemic corticosteroid therapy to be continued. Children are more prone to systemic adverse effects because they can absorb a higher amount of topical corticosteroids.
The application of topical corticosteroids should be discontinued, and appropriate treatment should be initiated if irritation occurs.
Long-term topical corticosteroid use can result in atrophy of the skin and subcutaneous tissues. Even brief use may cause skin thinning in areas such as the face, flexor regions, or skin creases. For this reason, care should be taken and these drugs used sparingly, especially in vulnerable places.
When dermatological infections are present, it is advisable to start using an appropriate antifungal or antibacterial treatment. The corticosteroid should be stopped until the infection is adequately managed if a positive response does not occur immediately.
Clinical Studies:
Eight researchers independently assessed the clinical efficacy of Fluocinonide 0.05 percent in a three-week, double-blind, paired-comparison experiment involving 240 patients. Half of the researchers compared Fluocinonide emollient cream with Betamethasone valerate 0.1 percent for atopic dermatitis, while the other four researchers compared Fluocinonide with Triamcinolone acetonide 0.1 percent cream for psoriasis treatment. Statistical analysis demonstrated that Fluocinonide excelled among the comparative drugs in terms of clinical responses.
Specific Considerations:
Pregnancy: In animal studies, corticosteroids have shown harmful effects on the developing fetus when used in significant amounts. There are no well-controlled studies in pregnant women for topical use. Therefore, topical corticosteroids like Fluocinonide should be used during pregnancy only if clearly needed, in small amounts, and for a short duration.
Lactation: Systemic corticosteroids can pass into breast milk, but it is unclear how much of a topical steroid is absorbed and reaches the milk. Breastfeeding mothers must take this medication with caution, and it is advised to consult the doctor before starting this.
Kid Patients: The medication must be used with caution. Long-term prolonged use may cause hormonal disturbances and Cushing’s syndrome.
Geriatric Patients: There are no studies in individuals above 65 years to assess safety. Therefore, Fluocinonide should be used carefully in older adults, with appropriate dose selection.
